Homoeopathic treatment of anxiety in adults

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1.Patients suffering from GAD (ICD code F41.1) diagnosed as per DSM-V criteria diagnosis confirmed through HAM-A (score 8-23). Initial screening for potential GAD cases will be done by using GAD-2 scoring (GAD 2 score 3 or higher)

2.Age between 18 and 65 years

3.Patients of either sex

4.Literate patients; ability to read English, Hindi and/or Bengali

5.Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires

6.Patients undergoing any treatment for GAD included after discontinuing the same following a washout period of 15 days if the patient agreed.

Exclusion Criteria

1.Minimal (HAM-A score 7 or less) and severe (HAM-A score 24 or more).

2.A primary psychiatric diagnosis other than GAD.

3.Suicidal tendency, pertinent current medications (anti-depressants, mood stabilizers or anti-psychotics, regular use of benzodiazepines, opioid based analgesics)

4.Three or more failed trials of pharmacotherapy for current GAD episode

5.Recently commenced psychotherapy

6.Patient unwilling to discontinue the antipsychotic or any other antidepressant medicine

7.Known clinical uncontrolled systemic disorder like uncontrolled diabetes, uncontrolled hypertension.

8.Vulnerable population- unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people.

9.Other uncontrolled or life-threatening illness affecting quality of life or any organ failure

10.Pregnant and puerperal women, lactating mothers

11.Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence

12.Self-reported immune-compromised state

13.Already undergoing homoeopathic treatment for chronic disease within last 6 months.

14.Simultaneous participation in any other clinical trail.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hamilton Anxiety Rating Scale (HAM-A)Timepoint: At baseline, every month, up to 3 months

Secondary Outcome Measures

Name	Time	Method
Generalized Anxiety Disorder 7 (GAD-7) questionnaireTimepoint: At baseline, every month, up to 3 months;Hamilton Depression Rating Scale (HDRS) questionnaireTimepoint: At baseline, every month, up to 3 months;Patient Health Questionnaire (PHQ9)Timepoint: At baseline, every month, up to 3 months